Three hospitals have sued CVS Health alleging the company redirected $250 million in savings from the 340B program. Mount Sinai Hospital, including St. Luke's-Roosevelt Hospital and Mount Sinai Beth ...
“When a program designed to deliver targeted assistance drives up system-wide costs, reform is no longer optional,” says health expert Sally Pipes. “It's necessary.” If a charity organization ...
Federal complaints by University of Michigan, University of Kansas Hospital Authority, and Mount Sinai entities seek recovery of approximately $250 million in alleged 340B savings diversion from ...
The 340B program allows certain nonprofit hospitals to buy prescription drugs at a significant discount. Larger urban hospitals generate most of the 340B revenue, while smaller rural clinics struggle ...
As U.S. healthcare costs, overall, increase each year, Rachelle Schultz, president and CEO of Winona Health, knows that pharmaceutical spending is her health system’s fastest-growing expense — as much ...
Federal regulations permit the drug to be dispensed by mail without a doctor's visit, but after an appeals court rules against that policy, Justice Samuel Alito halts any change until the Supreme ...
Keith Harvey is CEO of Cook Area Health Services, better known as Scenic Rivers Health, a group of nonprofit medical and dental clinics in the northeast Minnesota hinterlands. Scenic Rivers Health ...
Forbes contributors publish independent expert analyses and insights. I am a cable news contributor and professor of journalism. This voice experience is generated by AI. Learn more. This voice ...
The 340B Drug Pricing Program was created in 1992 to increase access to hospital outpatient medications for low‐income and uninsured patients by allowing covered entities that serve these patients to ...
The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking behaviors, says the American College of Physicians (ACP). In a new policy, ...
In February 2026, the Department of Justice filed amicus briefs supporting pharmaceutical manufacturers, asserting that Rhode Island and Colorado’s 340B laws conflict with the federal 340B Program and ...
AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount program with a lawsuit that challenges the definition of what it means to be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results